Tag:

R&D

Latest Headlines

Latest Headlines

Flailing Wilex finds a lifeline as Roche steps in with an ADC deal

Germany's Wilex has long been on the way out of biotech, but a new collaboration with Roche provides the company with some cash up front and a shot at down-the-line royalties.

Alnylam trumpets early promise for its Sanofi-partnered RNAi drug

Alnylam's in-development RNAi treatment successfully staved off nerve damage related to a rare disease in an ongoing study, the biotech said, early but promising results as the company heads into Phase III with partner Sanofi in tow.

MGH investigator Tanzi claims breakthrough will 'revolutionize' Alzheimer's R&D

Massachusetts General Hospital investigator Rudy Tanzi has created a new "Alzheimer's-in-a-dish" approach to growing brain cells that he claims provides clear proof of the much-debated amyloid hypothesis as well as a solid target for the disease. And now he reportedly plans to race ahead with his new research process to find a potential megablockbuster drug that can stop the disease in its tracks.

Covance and Novartis team up with eyes on Big Data

Covance has joined forces with Novartis to develop new ways to help drug developers quickly integrate and analyze huge swaths of study data.

Harvard scientists develop super-repellent device coating

As med tech companies search for innovative ways to improve device implantation and patient outcomes, a new coating technology from Harvard University scientists could reduce blood clotting and bacterial infection associated with commonly used medical devices.

Parexel expands in the U.K. after an eClinical buyout

Parexel International is widening its presence in Nottingham, U.K., tapping local grant funds to consolidate some outposts with plans to grow around its latest acquisition.

ISB teams with Google for NCI Cancer Genomics Cloud project

The list of life science data projects underpinned by Google keeps getting longer. Having signed up to the BRAIN Initiative last week, Google has now teamed up with ISB and SRA International to work on a project for the National Cancer Institute.

UC Davis researchers solve century-old bluetongue virus mystery

Researchers at the University of California, Davis, have solved a century-old mystery by discovering that the bluetongue virus that affects cattle and sheep survives winter by reproducing in midges, which spread the virus.

Novartis taps Oxford BioMedica in $90M immuno-oncology deal

Novartis has expanded its relationship with the U.K.'s Oxford BioMedica, signing a deal worth up to $90 million that will support the drugmaker's efforts in CAR-T immunotherapies.

Isis rolls into Phase III with an orphan drug as it waits on Biogen

Isis Pharmaceuticals has kicked off a Phase III trial on ISIS-SMNrx, a treatment for the rare spinal muscular atrophy, moving forward with the orphan drug as partner Biogen Idec considers whether to take the plunge on the program.